Cited by 5,514Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchNatural Compounds in Disease Treatment

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

The Pathogenesis of Rheumatoid Arthritis

McInnes, Iain B., Schett, Georg·2011·New England Journal of Medicine

DOI 10.1056/nejmra1004965

Open this paper in CoChat — free account

Abstract

The increased understanding of the immune mechanisms of rheumatoid arthritis has led to the development of a considerable number of new therapeutic agents that alter the natural history of the disease and reduce mortality.

Integrity signals

Registry

Crossref · 10.1056/nejmra1004965

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis
Schuerwegh, A. J., Ioan‐Facsinay, A., Dorjée, A. L., Roos, J. A. D. M. D., Bajema, I. M., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913054107 · Cited by 94
Retracted
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,959
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
Gregersen, P. K., Silver, J., & WINCHESTER, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,633
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2094 · Cited by 2,576
Self-citation
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
Rantapää‐Dahlqvist, S., Jong, B. A. W. D., Berglin, E. H., Hallmans, G., Wadell, G., Stenlund, H. C., Sundin, U., & VENROOIJ, W. J. V. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,946
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grünewald, J., Rönnelid, J., Harris, H. E., Ulfgren, A., Rantapää‐Dahlqvist, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21575 · Cited by 1,516

Show all 100 references

Research works printed but not linked: 5

Scher JU, 2010, Arthritis Rheum, 62, 1390
Szekanecz Z, 2009, Front Biosci (Elite Ed), 1, 44
Aupperle KR, 1998, Am J Pathol, 152, 1091
Gravallese EM, 1998, Am J Pathol, 152, 943
Jacobsson LT, 2005, J Rheumatol, 32, 1213

Sorted by citations

Items 201–300 of 1,011

Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases
Francisco, V., Ruiz‐Fernández, C., Pino, J., Mera, A., González-Gay, M. Á., Gómez, R., Lago, F., Mobasheri, A., & Gualillo, O. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.030 · Cited by 182
“Rheumatoid arthritis is a chronic inflammatory joint disease defined by synovial membrane inflammation and hyperplasia ("swelling"), destruction of cartilage and bone ("deformity"), production of autoantibodies (rheumatoid factor and anti-citrullinated protein antibody) autoimmune disease, and systemic features like p…”
Background
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
Scott, F. I., Mamtani, R., Brensinger, C. M., Haynes, K., Fuxench, Z. C. C., Zhang, J., Chen, L., Xie, F., Yun, H., Osterman, M. T., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.3029 · Cited by 183
Advances in kinase targeting: current clinical use and clinical trials
Rask‐Andersen, M., Zhang, J., Fabbro, D., & Schiöth, H. B. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.007 · Cited by 186
The interplay between host immune cells and gut microbiota in chronic inflammatory diseases
Kim, D.-H., Zeng, M. Y., & Núñez, G. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.24 · Cited by 191
Adenosine and Inflammation: Here, There and Everywhere
Pasquini, S., Contri, C., Borea, P. A., Vincenzi, F., & Varani, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147685 · Cited by 190
Activation of Nrf2/HO-1 Pathway by Nardochinoid C Inhibits Inflammation and Oxidative Stress in Lipopolysaccharide-Stimulated Macrophages
Luo, J.-F., Shen, X., Lio, C.-K., Dai, Y., Cheng, C., Liu, J.-X., Yao, Y.-D., Yu, Y., Xie, Y., Luo, P., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00911 · Cited by 181
“Antioxidant protein HO-1 has anti-oxidative and antiinflammatory effects (Linton and Fazio, 2003; McInnes and Schett, 2011).”
Background
Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles
Hong, M., Li, Z., Liu, H., Zheng, S., Zhang, F., Zhu, J., Shi, H., Ye, H., Chou, Z., Gao, L., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.018 · Cited by 182
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
Seeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 185
A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research
Yadav, V., Krishnan, A., & Vohora, D. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112255 · Cited by 196
Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis
Liu, H., Li, R., Liu, T., Yang, L., Yin, G., & Xie, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01912 · Cited by 179
Rituximab for the treatment of rheumatoid arthritis: an update
Mok, C. C. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s41645 · Cited by 177
T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway
Bözec, A., Zaiss, M. M., Kagwiria, R., Voll, R. E., Rauh, M., Chen, Z., Mueller-Schmucker, S. M., Kroczek, R. A., Heinzerling, L., Moser, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007764 · Cited by 178
Self-citation
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
Arts, R. J. W., Joosten, L. A. B., & Netea, M. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00298 · Cited by 183
Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages
Vogelpoel, L. T. C., Hansen, I. S., Rispens, T., Muller, F. J. M., van Capel, T. M. M., Turina, M. C., Vos, J. B., Baeten, D., Kapsenberg, M. L., de Jong, E. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6444 · Cited by 176
Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes
Tsuchida, A. I., Beekhuizen, M., Hart, M. C. `., Radstake, T. R. D. J., Dhert, W. J. A., Saris, D. B. F., van Osch, G. J. V. M., & Creemers, L. B. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0441-0 · Cited by 177
Human neutrophils in auto-immunity
Thiéblemont, N., Wright, H. L., Edwards, S. W., & Witko‐Sarsat, V. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.004 · Cited by 179
The IL-33/ST2 axis: Role in health and disease
la Fuente, M. D., MacDonald, T. T., & Hermoso, M. A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.017 · Cited by 171
Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis
Lin, J., Liu, J., Davies, M. L., & Chen, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146351 · Cited by 173
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis
Bruno, M. C., Cristiano, M. C., Celia, C., d’Avanzo, N., Mancuso, A., Paolino, D., Wolfram, J., & Fresta, M. (2022) · ACS Nano · doi:10.1021/acsnano.2c06393 · Cited by 178
The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapy
Brzustewicz, E., & Bryl, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.08.260 · Cited by 196
Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
Tateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · Cells · doi:10.3390/cells8080818 · Cited by 175
“These inflammatory cytokines activate osteoclasts, leading to bone destruction [1] (Figure 2).”
Background
Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways
Liu, C., He, L., Wang, J., Wang, Q., Sun, C., Li, Y., Jia, K., Wang, J., Xu, T., Ming, R., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113039 · Cited by 162
Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice
Seeling, M., Hillenhoff, U., David, J. P., Schett, G. A., Tuckermann, J. P., Lux, A., & Nimmerjahn, F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301001110 · Cited by 174
Self-citation
Osteoporosis in Rheumatic Diseases
Adami, G., Fassio, A., Rossini, M., Caimmi, C., Giollo, A., Orsolini, G., Viapiana, O., & Gatti, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235867 · Cited by 179
“Local and systemic bone loss are hallmarks of rheumatoid arthritis (RA) that result from the deterioration of both trabecular and cortical bone [8,9].”
Background
he role of TNF-α in rheumatoid arthritis: a focus on regulatory T cells
Farrugia, M., & Baron, B. (2016) · Journal of Clinical and Translational Research · doi:10.18053/jctres.02.201603.005 · Cited by 169
Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity
Watad, ‬., Azrielant, S., Bragazzi, N. L., Sharif, Κ., David, P., Katz, I., Aljadeff, G., Quaresma, M., Tanay, G., Adawi, M., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.001 · Cited by 167
The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis
Orr, C. K., Najm, A., Young, F., McGarry, T., Biniecka, M., Fearon, U., & Veale, D. J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00185 · Cited by 169
“Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disorder characterized by synovial proliferation and degradation of articular cartilage and bone (1).”
Background
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease
Weber, B., Giles, J. T., & Liao, K. P. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00969-7 · Cited by 185
Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases
Chen, B., Sun, L., & Zhang, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.009 · Cited by 170
Anti‐inflammatory effects of polyphenols in arthritis
Oliviero, F., Scanu, A., Zamudio-Cuevas, Y. E., Punzi, L., & Spinella, P. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8664 · Cited by 168
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
Tanaka, T., Narazaki, M., Ogata, A., & Kishimoto, T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.009 · Cited by 166
The genus Achyranthes : A review on traditional uses, phytochemistry, and pharmacological activities
He, X., Wang, X., Fang, J., Chang, Y., Ning, N., Guo, H., Huang, L., & Huang, X. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.035 · Cited by 167
Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis
Chuang, S.-Y., Lin, C.-H., Huang, T., & Fang, J. (2018) · Nanomaterials · doi:10.3390/nano8010042 · Cited by 165
IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels
Robert, M., & Miossec, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2018.00364 · Cited by 181
“Structural damage in RA includes cartilage destruction and bone erosion (42).”
Background
Melatonin attenuates TNF‐α and IL‐1β expression in synovial fibroblasts and diminishes cartilage degradation: Implications for the treatment of rheumatoid arthritis
Huang, C., Chiou, C., Liu, S., Hu, S., Su, C., Tsai, C., & Tang, C. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12560 · Cited by 165
Interluekin-17A (IL17A)
Chen, K., & Kolls, J. K. (2017) · Gene · doi:10.1016/j.gene.2017.01.016 · Cited by 170
Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody
Fischer, J. A. A., Hueber, A. J., Wilson, S. L., Galm, M., Baum, W., Kitson, C., Auer, J., Lorenz, S. H., Moelleken, J., Bader, M., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38896 · Cited by 167
Self-citation
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Cui, J., Stahl, E. A., Saevarsdóttir, S., Miceli‐Richard, C., Diogo, D., Trynka, G., Raj, T., Mirkov, M. U., Canhão, H. M., Ikari, K., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003394 · Cited by 165
Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis
Shin, T., Kim, H.-S., Kang, T., Lee, B.-C., Lee, H.-Y., Kim, Y.-J., Shin, J., Seo, Y., Choi, S. W., Lee, S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.442 · Cited by 163
The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology
Kiss, M., Czimmerer, Z., & Nagy, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.044 · Cited by 166
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Coates, L. C., FitzGerald, O., Helliwell, P., & Paul, C. F. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.012 · Cited by 168
K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis
Christensen, A. D., Haase, C., Cook, A. D., & Hamilton, J. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00213 · Cited by 164
Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome
Dudics, S., Langan, D., Meka, R. R., Venkatesha, S. H., Berman, B., Che, C., & Moudgil, K. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092508 · Cited by 161
Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis
Qiu, J., Wu, B., Goodman, S. B., Berry, G. J., Goronzy, J. J., & Weyand, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652771 · Cited by 170
Folate-targeted nanoparticles for rheumatoid arthritis therapy
Nogueira, E., Gomes, A. C., Preto, A., & Cavaco-Paulo, A. M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.365 · Cited by 163
A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain
Polykratis, A., Martens, A., Eren, R. O., Shirasaki, Y., Yamagishi, M., Yamaguchi, Y., Uemura, S., Miura, M., Holzmann, B., Kollias, G. A., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0324-3 · Cited by 162
Relationship between Periodontitis and Rheumatoid Arthritis: Review of the Literature
Araújo, V. M. A., de Melo, I. M., & Lima, V. (2015) · Mediators of Inflammation · doi:10.1155/2015/259074 · Cited by 160
Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects
Wang, Q., Ye, C., Shukun, S., Li, R., Shi, X., Wang, S., Zeng, X., Kuang, N., Liu, Y., Shi, Q., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.027 · Cited by 160
Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
Jung, S. M., Kim, K., Yang, C. W., Park, S., & Ju, J. H. (2014) · Journal of Immunology Research · doi:10.1155/2014/263625 · Cited by 165
How the microbiota shapes rheumatic diseases
de Wiele, T. V., Praet, J. T. V., Marzorati, M., Drennan, M. B., & Elewaut, D. S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.85 · Cited by 163
Location, location, location: how the tissue microenvironment affects inflammation in RA
Buckley, C. D., Ospelt, C., Gay, S., & Midwood, K. S. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00570-2 · Cited by 162
Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
Chen, Z., Xiong, M., Tian, J., Song, D., Duan, S., & Zhang, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02259-6 · Cited by 163
Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity
Veselinović, M., Barudzic, N. S., Vuletic, M. S., Zivkovic, V. I., Lucic, A. T., Djuric, D. M., & Jakovljevic, V. L. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2006-6 · Cited by 158
Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis
Koopman, F. A., van Maanen, M. A., Vervoordeldonk, M. J., & Tak, P. P. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12626 · Cited by 163
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2019) · Pharmacological Reviews · doi:10.1124/pr.117.014878 · Cited by 163
“Rheumatoid arthritis (RA) is a common autoimmune disease, which causes both joint inflammation and systemic complications, progressive disability, early death, and high socioeconomic costs (McInnes and Schett, 2011).”
Background
The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment
Wang, X., Fan, D., Cao, X., Ye, Q., Wang, Q., Zhang, M., & Xiao, C. (2022) · Antioxidants · doi:10.3390/antiox11061153 · Cited by 176
Overview of Rheumatoid Arthritis and Scientific Understanding of the Disease
Jahid, M., Khan, K., Rehan-Ul-Haq, & Ahmed, R. S. (2023) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.20230801.oo · Cited by 158
Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women , , ,
Hu, Y., Costenbader, K. H., Gao, X., Daabil, M. A., Sparks, J. A., Solomon, D. H., Hu, F. B., Karlson, E. W., & Lü, B. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086918 · Cited by 166
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D. R., Барбараш, О. Л., Vatutin, M. T., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 161
Self-citation
Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review
Meade, T., Manolios, N., Cumming, S., Conaghan, P. G., & Katz, P. (2017) · Arthritis Care & Research · doi:10.1002/acr.23243 · Cited by 157
Ten weeks of high-intensity interval walk training is associated with reduced disease activity and improved innate immune function in older adults with rheumatoid arthritis: a pilot study
Bartlett, D. B., Willis, L. H., Slentz, C. A., Hoselton, A. L., Kelly, L., Huebner, J. L., Kraus, V. B., Moss, J. B., Muehlbauer, M. J., Spielmann, G., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1624-x · Cited by 159
“Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by swollen and painful joints, synovial inflammation, deformation of cartilage and bone structures, and a dysfunctional autoreactive immune system [1].”
Background
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
Favalli, E. G. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00219-2 · Cited by 164
Tumor Necrosis Factor α Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts
Lee, A., Qiao, Y., Grigoriev, G., Chen, J., Park‐Min, K., Park, S. H., Ivashkiv, L. B., & Kalliolias, G. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37853 · Cited by 159
Inducible nitric oxide synthase inhibitors: A comprehensive update
Minhas, R., Bansal, Y., & Bansal, G. (2019) · Medicinal Research Reviews · doi:10.1002/med.21636 · Cited by 160
“Peroxynitrites also cause depletion of glutathione (GSH) that activates nuclear factor‐κB (NF‐κB) leading to cartilage destruction and rheumatic conditions.(13) Proinflammatory cytokines such as interferon‐γ (IFN‐γ), interleukin‐1β (IL‐1β), and tumor necrosis factor‐α (TNF‐α),”
Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy
Qindeel, M., Ullah, M. H., Din, F. U., Ahmed, N., & Rehman, A. U. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.016 · Cited by 158
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
Rech, J., Taşçılar, K., Hagen, M., Kleyer, A., Manger, B., Schönau, V., Hueber, A. J., Kleinert, S., Baraliakos, X., Braun, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02650-8 · Cited by 154
Self-citation
Hypoxia and its implications in rheumatoid arthritis
Quiñonez-Flores, C. M., González‐Chávez, S. A., & Pacheco‐Tena, C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0281-0 · Cited by 165
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis
Artacho, A., Isaac, S., Nayak, R. R., Flor‐Duro, A., Alexander, M., Koo, I., Manasson, J., Smith, P. B. W., Rosenthal, P., Homsi, Y., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41622 · Cited by 162
Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases
György, B., Szabó, T. G., Turiák, L., Wright, M., Herczeg, P., Lédeczi, Z., Kittel, Á., Polgar, A. A., Tóth, K., Dérfalvi, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049726 · Cited by 152
TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits
Diogo, D., Bastarache, L. A., Liao, K. P., Graham, R., Fulton, R. S., Greenberg, J. D., Eyre, S., Bowes, J., Cui, J., Lee, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122271 · Cited by 154
Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis
Kay, A. G., Long, G., Tyler, G., Stefan, A. L., Broadfoot, S. J., Piccinini, A. M., Middleton, J., & Kehoe, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-18144-w · Cited by 152
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study
Takeuchi, T., Tanaka, Y., Iwasaki, M., Ishikura, H., Saeki, S., & Kaneko, Y. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208279 · Cited by 151
Th2 and eosinophil responses suppress inflammatory arthritis
Zhu, C., Andreev, D., Oeser, K., Krljanac, B., Hueber, A. J., Kleyer, A., Voehringer, D., Schett, G. A., & Bözec, A. (2016) · Nature Communications · doi:10.1038/ncomms11596 · Cited by 155
Self-citation
Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity
Förger, F., & Villiger, P. M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0351-2 · Cited by 155
Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis
Gao, W., McCormick, J., Connolly, M., Balogh, E., Veale, D. J., & Fearon, U. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204105 · Cited by 154
The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study
Kato, E., Sawada, T., Tahara, K., Hayashi, H., Tago, M., Mori, H., Nishino, J., Matsui, T., & Tohma, S. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12998 · Cited by 149
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis
Adami, G., & Saag, K. G. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0836-7 · Cited by 149
Distinguishing rheumatoid arthritis from psoriatic arthritis
Merola, J. F., Espinoza, L. R., & Fleischmann, R. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000656 · Cited by 151
“Reprinted from Coates et al(29) and Perera et al.(28) IFN, interferon; IL, interleukin; MHC, major histocompatibility complex; PsA, psoriatic arthritis; Pso, psoriasis; RA, rheumatoid arthritis; TCR, T cell receptor; TGF-β, transforming growth factor-β; Th, T helper; TNF-α, tumour necrosis factor-α.”
Method
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Arjomandnejad, M., Kopec, A. L., & Keeler, A. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020287 · Cited by 154
Anaemia in inflammatory rheumatic diseases
Weiss, G., & Schett, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.183 · Cited by 146
Self-citation
The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
Paulissen, S. M. J., van Hamburg, J. P., Dankers, W., & Lubberts, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.002 · Cited by 148
Polyphenols Targeting MAPK Mediated Oxidative Stress and Inflammation in Rheumatoid Arthritis
Behl, T., Upadhyay, T., Singh, S., Chigurupati, S., Alsubaiyel, A. M., Mani, V., Vargas-De-La-Cruz, C. B., Uivaroșan, D., Bustea, C., Sava, C. N., et al. (2021) · Molecules · doi:10.3390/molecules26216570 · Cited by 148
Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model
Koo, S., Sohn, H. S., Kim, T. H., Yang, S., Jang, S. Y., Ye, S., Choi, B., Kim, S. H., Park, K. S., Shin, H. M., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01523-y · Cited by 151
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
Peres, R. S., Liew, F. Y., Talbot, J., Carregaro, V., de Oliveira, R. D. R., Almeida, S. C. L., França, R. F. D. O., Donate, P. B., Pinto, L. G., Ferreira, F. I. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424792112 · Cited by 145
From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
Wu, C., Yang, H., Luo, S., & Lai, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020686 · Cited by 155
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis
Hazlewood, G. S., Barnabe, C. C. M., TOMLINSON, G. A., Marshall, D. A., Devoe, D. J. A., & Bombardier, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010227.pub2 · Cited by 145
Are inflammatory cells increased in painful human tendinopathy? A systematic review
Dean, B. J. F., Gettings, P., Dakin, S. G., & Carr, A. J. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-094754 · Cited by 148
Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses
Yoon, B. R., Oh, Y.-J., Kang, S. W., Lee, E. B., & Lee, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00053 · Cited by 144
Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells
Tian, Y., Zhang, F., Qiu, Y., Wang, S., Li, F., Zhao, J., Pan, C., Tao, Y. K., Yu, D., & Wei, W. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00764-3 · Cited by 148
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
Huppler, A. R., Bishu, S., & Gaffen, S. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3893 · Cited by 147
Vitamin D and rheumatoid arthritis
Kostoglou‐Athanassiou, I., Athanassiou, P., Lyraki, A., Raftakis, I., & Antoniadis, C. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812471070 · Cited by 146
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
Geusens, P. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12438080 · Cited by 145
A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis
Schrepf, A., Kaplan, C. M., Ichesco, E., Larkin, T. E., Harte, S. E., Harris, R. E., Murray, A. D., Waiter, G. D., Clauw, D. J., & Basu, N. (2018) · Nature Communications · doi:10.1038/s41467-018-04648-0 · Cited by 144
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
Biggioggero, M., Crotti, C., Becciolini, A., & Favalli, E. G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s150580 · Cited by 147
Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases
Ishibashi, T. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990507 · Cited by 141
Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases: Diagnosis and Clinical Management
Mays, J. W., Sarmadi, M., & Moutsopoulos, N. M. (2012) · Journal of Evidence Based Dental Practice · doi:10.1016/s1532-3382(12)70051-9 · Cited by 141
Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis
Lee, J.-H., Kim, B.-J., Jin, W. J., Kim, H., Ha, H., & Lee, Z. H. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1353-6 · Cited by 143
Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
Park‐Min, K., Lim, E., Lee, M. J., Park, S. H., Γιαννοπούλου, Ε., Yarilina, A., van der Meulen, M. C. H., Zhao, B., Smithers, N. N., Witherington, J. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6418 · Cited by 141
NETosis as Source of Autoantigens in Rheumatoid Arthritis
Corsiero, E., Pratesi, F., Prediletto, E., Bombardieri, M., & Migliorini, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00485 · Cited by 140
Recent advances in nanomedicines for the treatment of rheumatoid arthritis
Wang, Q., & Sun, X. (2017) · Biomaterials Science · doi:10.1039/c7bm00254h · Cited by 139

Authors: McInnes, I. B., & Schett, G.
Affiliations: University of Glasgow (GB)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
ORCID: McInnes, Iain B.
Schett, Georg
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-12-08
Volume: 365
Issue: 23
Pages: 2205-2219
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1004965
OpenAlex: W2110826367
Cited by: 5,514
References: 100
Citations by year: 2026: 313 · 2025: 415 · 2024: 439 · 2023: 443 · 2022: 469 · 2021: 493 · 2020: 465 · 2019: 409 · 2018: 399 · 2017: 394 · 2016: 379 · 2015: 300 · 2014: 276 · 2013: 204 · 2012: 111
FWCI: 27.90
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: rheumatoid arthritis, pathogenesis, immune mechanisms, disease-modifying antirheumatic drugs, mortality reduction
MeSH terms: Arthritis, Rheumatoid, Humans, Antirheumatic Agents, Gene-Environment Interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Pathogenesis of Rheumatoid Arthritis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks